12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Idera proposes follow-on

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass.
Business: Cancer, Infectious, Autoimmune
Date announced:...

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >